Abramson S - Search Results

1

Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited.

Belmont HM, Buyon J, Giorno R, Abramson S. Belmont HM, et al. Among authors: abramson s. Arthritis Rheum. 1994 Mar;37(3):376-83. doi: 10.1002/art.1780370311. Arthritis Rheum. 1994. PMID: 7510492

2

Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.

Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S. Belmont HM, et al. Among authors: abramson s. Arthritis Rheum. 1986 Sep;29(9):1085-9. doi: 10.1002/art.1780290905. Arthritis Rheum. 1986. PMID: 3489467

3

The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.

Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB. Tseng CE, et al. Arthritis Rheum. 2006 Nov;54(11):3623-32. doi: 10.1002/art.22198. Arthritis Rheum. 2006. PMID: 17075807 Free article. Clinical Trial.

4

Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.

Abramson SB, Buyon JP. Abramson SB, et al. Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):183-7. doi: 10.1111/j.1600-0897.1992.tb00787.x. Am J Reprod Immunol. 1992. PMID: 1285875 Review.

5

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.

Buyon JP, Tamerius J, Belmont HM, Abramson SB. Buyon JP, et al. Among authors: abramson sb. Arthritis Rheum. 1992 Sep;35(9):1028-37. doi: 10.1002/art.1780350907. Arthritis Rheum. 1992. PMID: 1418018

6

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus.

Ritchlin CT, Chabot RJ, Alper K, Buyon J, Belmont HM, Roubey R, Abramson SB. Ritchlin CT, et al. Among authors: abramson sb. Arthritis Rheum. 1992 Nov;35(11):1330-42. doi: 10.1002/art.1780351114. Arthritis Rheum. 1992. PMID: 1445450

7

Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.

Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB. Buyon JP, et al. Among authors: abramson sb. Arthritis Rheum. 1992 Jan;35(1):55-61. doi: 10.1002/art.1780350109. Arthritis Rheum. 1992. PMID: 1731815

8

Acute reversible hypoxemia in systemic lupus erythematosus.

Abramson SB, Dobro J, Eberle MA, Benton M, Reibman J, Epstein H, Rapoport DM, Belmont HM, Goldring RM. Abramson SB, et al. Ann Intern Med. 1991 Jun 1;114(11):941-7. doi: 10.7326/0003-4819-114-11-941. Ann Intern Med. 1991. PMID: 2024861

9

Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus.

Buyon JP, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R, Abramson SB. Buyon JP, et al. Among authors: abramson sb. Clin Immunol Immunopathol. 1988 Jan;46(1):141-9. doi: 10.1016/0090-1229(88)90014-1. Clin Immunol Immunopathol. 1988. PMID: 2961492

10

Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.

Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB. Hopkins P, et al. Among authors: abramson sb. Arthritis Rheum. 1988 May;31(5):632-41. doi: 10.1002/art.1780310508. Arthritis Rheum. 1988. PMID: 3259882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

548 results

Search Page